211 related articles for article (PubMed ID: 15902285)
41. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513
[TBL] [Abstract][Full Text] [Related]
42. Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry.
Nenutil R; Smardova J; Pavlova S; Hanzelkova Z; Muller P; Fabian P; Hrstka R; Janotova P; Radina M; Lane DP; Coates PJ; Vojtesek B
J Pathol; 2005 Nov; 207(3):251-9. PubMed ID: 16161005
[TBL] [Abstract][Full Text] [Related]
43. Allelic loss during progression of follicular lymphoma.
Takeuchi S; de Vos S; Takeuchi N; Fermin AC; Grogan TM; Seo H; Said JW; Koeffler HP
Leuk Res; 2004 Jun; 28(6):567-9. PubMed ID: 15120932
[TBL] [Abstract][Full Text] [Related]
44. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.
Bellido M; Capello D; Altés A; Estivill C; Gaidano G; Pujol R; Bordes R; Baiget M; Saglio G; Sierra J; Nomdedéu JF
Haematologica; 2002 Sep; 87(9):908-17. PubMed ID: 12217802
[TBL] [Abstract][Full Text] [Related]
45. Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours.
Karube K; Martínez D; Royo C; Navarro A; Pinyol M; Cazorla M; Castillo P; Valera A; Carrió A; Costa D; Colomer D; Rosenwald A; Ott G; Esteban D; Giné E; López-Guillermo A; Campo E
J Pathol; 2014 Nov; 234(3):423-30. PubMed ID: 25141821
[TBL] [Abstract][Full Text] [Related]
46. A retrospective study of patients with follicular lymphoma (FL): identification of in situ FL or FL-like B cells of uncertain significance in lymph nodes resected at the time of previous surgery for carcinomas.
Morita K; Nakamine H; Nakai T; Takano M; Takeda M; Enomoto Y; Yoshii Y; Kanno M; Ohbayashi C
J Clin Pathol; 2015 Jul; 68(7):541-6. PubMed ID: 25862812
[TBL] [Abstract][Full Text] [Related]
47.
Musilova K; Devan J; Cerna K; Seda V; Pavlasova G; Sharma S; Oppelt J; Pytlik R; Prochazka V; Prouzova Z; Trbusek M; Zlamalikova L; Liskova K; Kruzova L; Jarosova M; Mareckova A; Kornauth C; Simonitsch-Klupp I; Schiefer AI; Merkel O; Mocikova H; Burda P; Machova Polakova K; Kren L; Mayer J; Zent CS; Trneny M; Evans AG; Janikova A; Mraz M
Blood; 2018 Nov; 132(22):2389-2400. PubMed ID: 30213873
[TBL] [Abstract][Full Text] [Related]
48. Methylation changes of SIRT1, KLF4, DAPK1 and SPG20 in B-lymphocytes derived from follicular and diffuse large B-cell lymphoma.
Frazzi R; Zanetti E; Pistoni M; Tamagnini I; Valli R; Braglia L; Merli F
Leuk Res; 2017 Jun; 57():89-96. PubMed ID: 28324774
[TBL] [Abstract][Full Text] [Related]
49. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles.
Almasri NM; Iturraspe JA; Braylan RC
Arch Pathol Lab Med; 1998 Jun; 122(6):539-44. PubMed ID: 9625422
[TBL] [Abstract][Full Text] [Related]
50. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
51. Predicting transformation in follicular lymphoma.
de Jong D; de Boer JP
Leuk Lymphoma; 2009 Sep; 50(9):1406-11. PubMed ID: 19606378
[TBL] [Abstract][Full Text] [Related]
52. In situ follicular lymphoma associated with overt B- or T-cell lymphomas in the same lymph node.
Carbone A; Della Libera D; Zannier L; Selva A; Ceolin P; Gualeni A; Canal B; Gloghini A
Am J Hematol; 2011 Dec; 86(12):E66-70. PubMed ID: 21956856
[TBL] [Abstract][Full Text] [Related]
53. p53 mutation is associated with progression in follicular lymphomas.
Sander CA; Yano T; Clark HM; Harris C; Longo DL; Jaffe ES; Raffeld M
Blood; 1993 Oct; 82(7):1994-2004. PubMed ID: 8400252
[TBL] [Abstract][Full Text] [Related]
54. p53 dysregulation in B-cell malignancies: More than a single gene in the pathway to hell.
Tessoulin B; Eveillard M; Lok A; Chiron D; Moreau P; Amiot M; Moreau-Aubry A; Le Gouill S; Pellat-Deceunynck C
Blood Rev; 2017 Jul; 31(4):251-259. PubMed ID: 28284458
[TBL] [Abstract][Full Text] [Related]
55. Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells.
Andréasson U; Dictor M; Jerkeman M; Berglund M; Sundström C; Linderoth J; Rosenquist R; Borrebaeck CA; Ek S
Am J Hematol; 2009 Dec; 84(12):803-8. PubMed ID: 19844990
[TBL] [Abstract][Full Text] [Related]
56. Early transformation event from follicular lymphoma: our experience of four cases.
Mehta A; Karki D; Gudapati P
Pol J Pathol; 2022; 73(2):166-175. PubMed ID: 36200794
[TBL] [Abstract][Full Text] [Related]
57. Gene expression profile of serial samples of transformed B-cell lymphomas.
de Vos S; Hofmann WK; Grogan TM; Krug U; Schrage M; Miller TP; Braun JG; Wachsman W; Koeffler HP; Said JW
Lab Invest; 2003 Feb; 83(2):271-85. PubMed ID: 12594241
[TBL] [Abstract][Full Text] [Related]
58. [Investigation for pathological interpretation criteria and its prognostic value for P53 expression in Chinese diffuse large B-cell lymphoma].
Shi YF; Gao ZF; Li XH; Guo LG; Zheng QL; Long MP; Deng LJ; Du TT; Jia L; Zhao W; Song XX; Li M
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1010-1015. PubMed ID: 36709106
[No Abstract] [Full Text] [Related]
59. Cell of origin of transformed follicular lymphoma.
Kridel R; Mottok A; Farinha P; Ben-Neriah S; Ennishi D; Zheng Y; Chavez EA; Shulha HP; Tan K; Chan FC; Boyle M; Meissner B; Telenius A; Sehn LH; Marra MA; Shah SP; Steidl C; Connors JM; Scott DW; Gascoyne RD
Blood; 2015 Oct; 126(18):2118-27. PubMed ID: 26307535
[TBL] [Abstract][Full Text] [Related]
60. Angiogenesis in non-Hodgkin's lymphoma: clinico-pathological correlations and prognostic significance in specific subtypes.
Jørgensen JM; Sørensen FB; Bendix K; Nielsen JL; Olsen ML; Funder AM; d'Amore F
Leuk Lymphoma; 2007 Mar; 48(3):584-95. PubMed ID: 17454603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
